<p>Images were acquired at 20×magnification. Control – mice without treatment, Bleomycin – mice treated with bleomycin only, EP – mice treated with EP, ECT – mice treated with ECT. (<b>A</b>) Illustration of FD leakage from blood vessels surrounding the tumor, when FD was injected <i>i.o.</i> before the therapy. Arrows indicate the position of the tumor. Scale bar is 2 mm. (<b>B</b>) Illustration of the constriction of blood vessels surrounding the tumor visualized by FD. The enlarged sections of images were taken at 20×magnification. Scale bar is 500 µm.</p
<p>(<b>A</b>) Filling of tumor blood vessels after <i>i.o.</i> injection of FD and increase of fluor...
<p>T2w-MRI and fused <sup>18</sup>F-FET MicroPET/CT images showing tumour progression 3–5 weeks afte...
<p>(A) The data represent mean tumor volumes ± SEM in 16K-Ad-treated (n = 8) or Null-Ad-treated (n =...
<p>Tumor blood vessels were visualized by fluorescence microscopy at 80×magnification. Control – mic...
<p>Tumor blood vessels were visualized by fluorescence microscopy. Control – mice without treatment,...
<p>Relative mean fluorescence intensity changes as a function of time in the tumor tissue, outside t...
<p>Yellow line outlines the tumor. (a) Pre contrast injection. (b) immediately post contrast injecti...
<p>(Model group): Pathological section from the model group treated with distilled water. The tumor ...
<p>Control – mice without treatment, Bleomycin – mice treated with bleomycin only, EP – mice treated...
<p>A: pre-treatment, B: day 12 of saline control, C: day 12 of bevacizumab/paclitaxel combination tr...
<p>Sections of tumors recovered from mice, untreated control and treated with either HB-19 or 5-FU (...
<p>PC-3-tumors, LNs and RNs were excised, cut in 100 µm sections and stained with anti-CD31 antibody...
<p>(A) Representative mice of the different groups 14 days after inoculation of the Dox-inducible NB...
<p>A) MF (2 mT, 50 Hz) exposed cells (right) in comparison with unexposed cells (left). B) The size ...
<p>Column A-D: A showcase of four representative mice, displaying a range in tumour volumes, is pres...
<p>(<b>A</b>) Filling of tumor blood vessels after <i>i.o.</i> injection of FD and increase of fluor...
<p>T2w-MRI and fused <sup>18</sup>F-FET MicroPET/CT images showing tumour progression 3–5 weeks afte...
<p>(A) The data represent mean tumor volumes ± SEM in 16K-Ad-treated (n = 8) or Null-Ad-treated (n =...
<p>Tumor blood vessels were visualized by fluorescence microscopy at 80×magnification. Control – mic...
<p>Tumor blood vessels were visualized by fluorescence microscopy. Control – mice without treatment,...
<p>Relative mean fluorescence intensity changes as a function of time in the tumor tissue, outside t...
<p>Yellow line outlines the tumor. (a) Pre contrast injection. (b) immediately post contrast injecti...
<p>(Model group): Pathological section from the model group treated with distilled water. The tumor ...
<p>Control – mice without treatment, Bleomycin – mice treated with bleomycin only, EP – mice treated...
<p>A: pre-treatment, B: day 12 of saline control, C: day 12 of bevacizumab/paclitaxel combination tr...
<p>Sections of tumors recovered from mice, untreated control and treated with either HB-19 or 5-FU (...
<p>PC-3-tumors, LNs and RNs were excised, cut in 100 µm sections and stained with anti-CD31 antibody...
<p>(A) Representative mice of the different groups 14 days after inoculation of the Dox-inducible NB...
<p>A) MF (2 mT, 50 Hz) exposed cells (right) in comparison with unexposed cells (left). B) The size ...
<p>Column A-D: A showcase of four representative mice, displaying a range in tumour volumes, is pres...
<p>(<b>A</b>) Filling of tumor blood vessels after <i>i.o.</i> injection of FD and increase of fluor...
<p>T2w-MRI and fused <sup>18</sup>F-FET MicroPET/CT images showing tumour progression 3–5 weeks afte...
<p>(A) The data represent mean tumor volumes ± SEM in 16K-Ad-treated (n = 8) or Null-Ad-treated (n =...